title: [Experience in the use of ditrastic in the therapy of psoriasis].
abstract: Forty-six patients suffering from psoriasis have been treated with ditrastic, a new drug for external application, manufactured by Orion, Finland. The drug is manufactured in the form of sticks weighing 2.4 g, containing 1.5 or 3% of dithranol, paraffin, and microcrystalline sulfur. These sticks are applied to psoriatic plaques once daily. The treatment has been effective.
authors.forename: I Ia
authors.initials: IIa
authors.lastname: Shakhtmeĭster
authors.forename: O Ia
authors.initials: OIa
authors.lastname: Kaukhova
authors.forename: N A
authors.initials: NA
authors.lastname: Kunin
authors.forename: E M
authors.initials: EM
authors.lastname: Shablinskaia
authors.forename: L G
authors.initials: LG
authors.lastname: Kozyreva
mesh_terms: D000293:Adolescent; D000328:Adult; D000875:Anthralin / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010232:Paraffin / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D013455:Sulfur / Q000627:therapeutic use*
chemical_list: D004338:Drug Combinations; C059206:ditrastic; D013455:Sulfur; D010232:Paraffin; D000875:Anthralin
vernacular_title: Opyt primeneniia ditrastika v terapii psoriaza.